A detailed history of Advisor Group Holdings, Inc. transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 70 shares of APLT stock, worth $644. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70
Holding current value
$644
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.35 - $8.5 $304 - $595
70 New
70 $0
Q1 2022

May 04, 2022

SELL
$1.48 - $6.22 $148 - $622
-100 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$15.44 - $24.23 $1,544 - $2,423
100 New
100 $2,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $442M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.